[{"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "77484", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1044-2017", "product_description": "Alka-Seltzer Original ( 325 mg Aspirin (NSAID), 1916 mg Analgesic, Sodium bicarbonate/Antacid, 1000 mg Anhydrous Citric Acid) Effervescent Tablets, 12-count carton,  Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981, UPC 016500040194", "product_quantity": "1,067,520 12-count cartons", "reason_for_recall": "Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.", "recall_initiation_date": "20170330", "center_classification_date": "20170801", "termination_date": "20200108", "report_date": "20170809", "code_info": "BTAH340; Exp. 02/19  BTAHCP0; Exp. 04/19  BTAHLW0; Exp. 06/19  BTAHLX0; Exp. 08/19  BTAHP10; Exp 08/19"}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71078", "recalling_firm": "South Coast Specialty Compounding, Inc.", "address_1": "9257 Research Dr", "address_2": "N/A", "postal_code": "92618-4286", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1415-2015", "product_description": "Bi-Est (estriol,estradiol), Progesterone Vaginal Suppository, Rx only, Manufactured by Park Compounding, Irvine, CA", "product_quantity": "24 suppositories (24 prescriptions)", "reason_for_recall": "Penicillin Cross Contamination: Multiple finished products potentially contaminated with penicillin.", "recall_initiation_date": "20150423", "center_classification_date": "20150902", "termination_date": "20160531", "report_date": "20150909", "code_info": "Lot #:  01052015@12  01132015@2  01132015@36  01132015@37  01152015@4  01162015@66  01202015@34  02112015@11  02112015@11  02252015@34  10312014@13  11042014@42  11052014@46  11072014@21  11122014@43  11122014@45  11182014@15  11192014@41  11242014@29  11262014@14  12022014@13  12102014@4  12192014@40  12222014@18    Exp. 07/15"}, {"status": "Terminated", "city": "Middletown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83200", "recalling_firm": "Geritrex, LLC", "address_1": "40 Commercial Ave", "address_2": "N/A", "postal_code": "10941-1444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-1527-2019", "product_description": "Preferred Plus Dioctyl Liquid Stool Softener (Docusate Sodium), 50mg/5mL, 16 FL. Oz. (1 PT.) 473 mL, Manufactured by RIJ Pharmaceutical Corp. 40 Commercial Avenue Middletown, NY 10941, Distributed by Kinray Inc. Whitestone, NY 11357, NDC 53807-216-16", "product_quantity": "15435 bottles", "reason_for_recall": "cGMP Deviations: Products may have microbial contamination.", "recall_initiation_date": "20190531", "center_classification_date": "20190725", "termination_date": "20240202", "report_date": "20190731", "code_info": "Lot #: 70603, 70604, 70612, Exp 6/19"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0347-2017", "product_description": "Chorionic Gonadotropin, Lyophilized, 3,500 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "1753 kits (number of vials per kit vary)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04212016@46, 05232016@215, 05232016@216, 07052016@89, 08042016@103, 09132016@116.  Known vial lot code: 04132016@91, 05162016@136, 06242016@96, 07282016@51, 09092016@20"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80118", "recalling_firm": "Guardian Pharmacy Services", "address_1": "7920 Elmbrook Dr Ste 108", "address_2": "N/A", "postal_code": "75247-4933", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-1056-2018", "product_description": "Glutathione 200 mg/mL 100ml. Rx Only. Packaged in 100 mL MDV vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247", "product_quantity": "2400 100-ml vials", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20180517", "center_classification_date": "20180808", "termination_date": "20201125", "report_date": "20180815", "code_info": "Lots: 58436:42 Use By: 05/22/2018; 58653:42 Use By: 06/12/2018; 58773:42, 58766:42, Use By: 06/21/2018; 58766:42 Use By: 06/20/2018;"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0636-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Ear Ringing, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955527527, NDC 57955-5275-2", "product_quantity": "1980 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 052516V Exp. 05/19; 052517E Exp. 05/20"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-705-2015", "product_description": "Histamine Diphosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66188", "recalling_firm": "Wellness Pharmacy, Inc.", "address_1": "3401 Independence Drive Suite 231", "address_2": "N/A", "postal_code": "35209-8326", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1035-2013", "product_description": "Dexpanthenol 250 mg/mL PF, Single Use Vial,  1 mL, WELLNESS PHARMACY, 1-800-227-2627", "product_quantity": "1355 Vials", "reason_for_recall": "Lack of Assurance of Sterility: The product lots are being recalled due to laboratory results indicating microbial contamination. The FDA was concerned test results obtained from the recalling firm's contract testing lab may not be reliable.", "recall_initiation_date": "20130823", "center_classification_date": "20130912", "termination_date": "20140603", "report_date": "20130918", "code_info": "Lot# 130605@52, Exp. 12/2/13", "more_code_info": ""}, {"status": "Ongoing", "city": "Wuhan", "state": "N/A", "country": "China", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85726", "recalling_firm": "Wuhan Bingbing Pharmaceutical Co., Ltd.", "address_1": "Building", "address_2": "F, No.5, Kangda Street", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1278-2020", "product_description": "LidoPro (lidocaine 4%, menthol 5%, methyl salicylate 4%) patch, 15 Patches per box, Manufactured For: Terrain Pharmaceuticals, Reno, NV 89501; NDC 53225-1023-1.", "product_quantity": "54,000 boxes", "reason_for_recall": "CGMP Deviations: due to the loss of product manufacturing records and retain product samples, there is no assurance that the product will remain within specification through the labeled expiration date.", "recall_initiation_date": "20200519", "center_classification_date": "20200528", "report_date": "20200603", "code_info": "Batch #: 170527, Exp 2020.05"}, {"status": "Terminated", "city": "Chatham", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71591", "recalling_firm": "Liberty Drug & Surgical", "address_1": "195 Main St", "address_2": "N/A", "postal_code": "07928-2405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Physicians, Medical Facilities, and Prescription Specific Patients in NJ and NY", "recall_number": "D-1399-2015", "product_description": "Methadone 10 mg/mL Injection, 10 mL vial, Rx only, Liberty Drug Compound Center, 195 Main St., PO Box 267, Chatham, NJ  07928.", "product_quantity": "5 vials", "reason_for_recall": "Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.", "recall_initiation_date": "20150615", "center_classification_date": "20150827", "termination_date": "20180423", "report_date": "20150902", "code_info": "Lot #: 05012015@5, Exp 06/16/15; 05152015@10, Exp 06/30/15"}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206918"], "brand_name": ["FONDAPARINUX SODIUM"], "generic_name": ["FONDAPARINUX SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-230", "55150-231", "55150-232", "55150-233"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["FONDAPARINUX SODIUM"], "rxcui": ["861356", "861360", "861363", "861365"], "spl_id": ["a193830a-dc25-412a-b047-d2fa77d9dbbc"], "spl_set_id": ["8ea61d0d-4403-4d9f-a946-85a459cc0aa0"], "package_ndc": ["55150-230-00", "55150-230-02", "55150-230-10", "55150-231-00", "55150-231-02", "55150-231-10", "55150-232-00", "55150-232-02", "55150-232-10", "55150-233-00", "55150-233-02", "55150-233-10"], "is_original_packager": [true], "unii": ["X0Q6N9USOZ"]}, "product_type": "Drugs", "event_id": "90925", "recalling_firm": "AuroMedics Pharma LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0020-2023", "product_description": "Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)", "product_quantity": "11,520 units", "reason_for_recall": "Subpotent Drug: Out of specification for assay", "recall_initiation_date": "20220930", "center_classification_date": "20221024", "termination_date": "20240918", "report_date": "20221102", "code_info": "Lot # CFN200020, EXP Nov. 2022", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU may be potentially mislabeled as    DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375710, Pedigree: W002694, EXP: 6/5/2014", "address_2": "", "product_quantity": "999 Capsules", "code_info": "LACTOBACILLUS ACIDOPHILUS, Capsule, 500 Million CFU has the following code    Pedigree: W002698, EXP: 6/5/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LACTOBACILLUS ACIDOPHILUS Capsule, 500 Million CFU, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 43292055746", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-562-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "West Columbia", "address_1": "4500 12th Street Ext", "reason_for_recall": "Incorrect labeling: Incorrect or missing lot and/or exp date", "address_2": "", "product_quantity": "19,390 syringes", "code_info": "Lots: SU9079A, SU9079B, Exp 4/5/2020", "center_classification_date": "20191028", "distribution_pattern": "Nationwide in the U.S.", "state": "SC", "product_description": "PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.", "report_date": "20191106", "classification": "Class III", "openfda": {}, "recalling_firm": "Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center", "recall_number": "D-0154-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84106", "termination_date": "20200507", "more_code_info": "", "recall_initiation_date": "20191021", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0743-2020", "product_description": "HYDROMORPHONE 2MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "4 syringes", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lots: 12112019@1 Exp. 12/20/2019; 12112019@6 Exp. 12/20/2019; 12162019@23 Exp. 12/25/2019; 12172019@7 Exp. 12/26/2019", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "307 ml total", "code_info": "All lots distributed between November 2014 and May 2015;    01082015@10, 7/7/2015; 12022014@44, 5/31/2015; 12192014@14, 6/17/2015;  01072015@22, 7/6/2015; 01262015@83, 7/25/2015; 02092015@12, 8/8/2015  02132015@5, 8/12/2015; 02202015@19, 8/19/2015; 02192015@24, 8/18/2015; 03022015@49, 8/29/2015; 03302015@1, 9/26/2015; 03312015@12, 9/27/2015; 04012015@63, 9/28/2015; 04162015@37, 10/13/2015; 05042015@37, 10/31/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (17.7 mg/0.59 mg/6 mcg)  Injectable, Sterile, Keep Frozen, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1764-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1700-2019", "product_description": "PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0955-30", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"country": "United States", "city": "Titusville", "address_1": "1125 Trenton-Harbourton Rd.", "reason_for_recall": "Labeling: Incorrect Instructions; Instructions included  for use with the Veridate dispenser contained instructions for the Dialpak dispenser.", "address_2": "", "product_quantity": "1,777 cartons", "code_info": "Lot # 18BM114, Exp. 03/2020", "center_classification_date": "20181106", "distribution_pattern": "Nationwide in the USA", "state": "NJ", "product_description": "Ortho-Novum 1/35 (norethindrone/ethinyl estradiol) Tablets, 1 mg/0.035 mg, 28-Day Regimen per pouch (NDC 50458-176-28), 6 Veridate Tablet Dispensers and 6 refills per carton (NDC 50458-176-06), Rx only, Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674; Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560.", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Janssen Pharmaceuticals, Inc.", "recall_number": "D-0217-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81289", "termination_date": "20191030", "more_code_info": "", "recall_initiation_date": "20181023", "postal_code": "08560", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Waynesboro", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81811", "recalling_firm": "Duren Health Mart Pharmacy", "address_1": "215 Dexter L Woods Memorial Blvd", "address_2": "N/A", "postal_code": "38485-2416", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "TN only", "recall_number": "D-0417-2019", "product_description": "Progesterone 10% cream, 12gm to 30gm per prescription, Rx only, Duren's Health Mart Pharmacy 215 Dexter Woods Blvd. Waynesboro, TN 38485, NDC 00000-0002-99", "product_quantity": "200 grams", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20181217", "center_classification_date": "20190128", "termination_date": "20220119", "report_date": "20190206", "code_info": "N/A"}, {"status": "Terminated", "city": "Tonawanda", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93154", "recalling_firm": "Pine Pharmaceuticals, LLC", "address_1": "355 Riverwalk Pkwy", "address_2": "N/A", "postal_code": "14150-5837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0058-2024", "product_description": "Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mL (100 mcg/0.1 mL) 1 mL syringes, Rx only, Compounded by: Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.", "product_quantity": "2176 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231002", "center_classification_date": "20231019", "termination_date": "20240515", "report_date": "20231025", "code_info": "Lot #: 67623, Exp. Date 10/15/2023; 67919, Exp. Date 10/29/2023; 68917, Exp. Date 12/16/2023; 69079, Exp. Date 12/23/2023; 69120, Exp. Date 12/24/2023"}, {"status": "Terminated", "city": "Chesterbrook", "state": "PA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA021977"], "brand_name": ["VYVANSE"], "generic_name": ["LISDEXAMFETAMINE DIMESYLATE"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "product_ndc": ["59417-101", "59417-102", "59417-103", "59417-104", "59417-105", "59417-106", "59417-107", "59417-115", "59417-116", "59417-117", "59417-118", "59417-119", "59417-120"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LISDEXAMFETAMINE DIMESYLATE"], "spl_id": ["78225b65-2133-4c6c-bfde-0f2b26e5b19f"], "spl_set_id": ["704e4378-ca83-445c-8b45-3cfa51c1ecad"], "package_ndc": ["59417-101-10", "59417-102-10", "59417-103-10", "59417-104-10", "59417-105-10", "59417-106-10", "59417-107-10", "59417-115-01", "59417-116-01", "59417-117-01", "59417-118-01", "59417-119-01", "59417-120-01"], "is_original_packager": [true], "unii": ["SJT761GEGS"]}, "product_type": "Drugs", "event_id": "75170", "recalling_firm": "Shire", "address_1": "1200 Morris Dr", "address_2": "N/A", "postal_code": "19087-5507", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0006-2017", "product_description": "Vyvanse (lisdexamfetamine dimesylate) Capsules 30 mg, 100 count bottle, Rx Only, Manufactured for: Shire US, Inc., Lexington, MA 02421, NDC 59417-103-10", "product_quantity": "7,680 bottles (768,000 capsules)", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20160902", "center_classification_date": "20161005", "termination_date": "20190308", "report_date": "20161012", "code_info": "Lot # AF3360B; Exp. 04/19"}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93940", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "N/A", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MN", "recall_number": "D-0325-2024", "product_description": "Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.", "product_quantity": "1,299 syringes", "reason_for_recall": "Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.", "recall_initiation_date": "20240122", "center_classification_date": "20240215", "report_date": "20240221", "code_info": "Lot #s:  20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024"}, {"country": "United States", "city": "Henderson", "address_1": "1850 Whitney Mesa Dr", "reason_for_recall": "Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility assurance and concerns associated with the quality control processes.", "address_2": "Suite 180", "product_quantity": "2 vials", "code_info": "Lot #: 130129300AEB, Exp 4/29/2013.", "center_classification_date": "20130516", "distribution_pattern": "Nationwide", "state": "NV", "product_description": "Buprenorphine Injection, all strengths and all presentations including Buprenorphine-0.3 30 mL, Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV  89014.", "report_date": "20130522", "classification": "Class II", "openfda": {}, "recalling_firm": "FVS Holdings, Inc. dba. Green Valley Drugs", "recall_number": "D-353-2013", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "64879", "termination_date": "20140321", "more_code_info": "", "recall_initiation_date": "20130410", "postal_code": "89014-2091", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Portland", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85955", "recalling_firm": "WALKER EMULSIONS INC", "address_1": "4401 Se Johnson Creek Blvd", "address_2": "N/A", "postal_code": "97222-9218", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US Distribution: Product distributed to sister plant site located in SC, and one donation made to consignee located in OR. Majority of hand sanitizer shipped to Canada (Health Canada has already received consignee information and classified the recall).", "recall_number": "D-1416-2020", "product_description": "Walker Emulsions Hand Sanitizer (60%), Non-Sterile Solution, Alcohol Antiseptic 60%, 1 Gallon, Topical Solution, Walker Emulsions Inc., 4401 SE Johnson Creek Blvd., Portland, OR 97222, NDC 74940-0415-1", "product_quantity": "N/A", "reason_for_recall": "Incorrect/Undeclared Excipients: Notification received from Health Canada that DA-2I Ethanol is a type not an approved for use in Hand Sanitizer.", "recall_initiation_date": "20200603", "center_classification_date": "20200728", "termination_date": "20240513", "report_date": "20200729", "code_info": "Lot # 209638", "more_code_info": ""}, {"status": "Ongoing", "city": "Oxnard", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96763", "recalling_firm": "Siddha Flower Essences, LLC.", "address_1": "2350 Eastman Ave Ste 107", "address_2": "N/A", "postal_code": "93030-7265", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide.", "recall_number": "D-0410-2025", "product_description": "temper tamer, 1 US fl oz. (29.6 mL), Homeopathic Oral Spray, Manufactured by: Siddha Flower Essences, Oxnard, CA, 93030  NDC 69779-020-01.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20250428", "center_classification_date": "20250506", "report_date": "20250514", "code_info": "Lot#  S22-26424D; Exp 9/27/2027", "more_code_info": ""}, {"country": "United States", "city": "Harriman", "address_1": "144 Route 17m Ste 4", "reason_for_recall": "Penicillin Cross Contamination: potentially contaminated with penicillin", "address_2": "", "product_quantity": "unknown", "code_info": "All lots", "center_classification_date": "20151202", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "ESTRIOL Capsules, Rx, compounded by Life Science Pharmacy Inc., Harriman, NY", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Life Science Pharmacy Inc", "recall_number": "D-0489-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71494", "termination_date": "20180611", "more_code_info": "", "recall_initiation_date": "20150608", "postal_code": "10926-3321", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-539-2015", "product_description": "Benztropine Mesylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0738-2023", "product_description": "diphenhydrAMINE 50 mg added to 0.9% sodium chloride 50 mL in 100 mL Partial Additive Bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7090-1.", "product_quantity": "3999 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-884155, Exp 05/03/2023; 37-885992, Exp 05/10/2023; 37-887348, Exp 05/16/2023; 37-887660, Exp 05/17/2023; 37-889052, Exp 05/23/2023; 37-891155, 37-891156, Exp 05/31/2023; 37-891443, Exp 06/01/2023; 37-892475, Exp 06/06/2023"}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "63488", "recalling_firm": "Valeant Pharmaceuticals", "address_1": "700 Rte 206 North", "address_2": "N/A", "postal_code": "08807", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-046-2013", "product_description": "AcneFree Acne Astringent Toner Pads (salicylic acid 2% w/v); 60-count pads per jar, Dist. by: University Medical Pharmaceuticals Corp., Irvine, CA  92618, UPC 7 88521 13551 6.", "product_quantity": "71,369 jars", "reason_for_recall": "Subpotent (Single Ingredient) Drug: This product was found to be subpotent for the salicyclic acid active ingredient.", "recall_initiation_date": "20121015", "center_classification_date": "20121106", "termination_date": "20130325", "report_date": "20121114", "code_info": "All lots with expiration dates between 10/10/12 through 10/10/14 of UPC 7 88521 13551 6"}, {"status": "Terminated", "city": "Atlanta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87268", "recalling_firm": "Wilshire Pharmaceuticals Inc", "address_1": "6 Concourse Pkwy NE", "address_2": "N/A", "postal_code": "30328-6117", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, TX", "recall_number": "D-0258-2021", "product_description": "Meclizine HCl Tablets, USP, 12.5 mg, 100 Tablets bottles, Rx Only, Mfd. for: Wilshire Pharmaceuticals, Inc., Atlanta, GA 30328, Product of India, NDC 52536-129-01", "product_quantity": "2112 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210204", "center_classification_date": "20210216", "termination_date": "20230602", "report_date": "20210224", "code_info": "Lot #: 18030318, Exp 03/2021"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-766-2015", "product_description": "Lisinopril active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "72174", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 SW 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "US Nationwide", "recall_number": "D-0008-2016", "product_description": "Daytrana (methylphenidate transdermal system), 30 mg over 9 Hour Patches (3.3 mg/hr), 30 Ct Carton, Rx Only, Manufactured for: Noven Therapies, LLC., Miami, FL 33186, by: Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC: 68968-5555-3", "product_quantity": "125,250 Patches", "reason_for_recall": "Defective Delivery System: Out of specification for z-statistic related to mechanical peel force.", "recall_initiation_date": "20150727", "center_classification_date": "20151006", "termination_date": "20190320", "report_date": "20151014", "code_info": "Lot #: 75983, Expiry: 11/15"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0754-2019", "product_description": "Dr. King's SafeCare Rx Constitutional Enhancer Constitution, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955014928, NDC 57955-0149-2", "product_quantity": "794 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 102016F Exp. 10/19; 022316D Exp. 02/19; 061716D Exp. 06/19"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: AMANTADINE HCL, Tablet, 100 mg may have potentially been mislabeled as one of the following drugs:  MAGNESIUM CHLORIDE, Tablet, 64 mg, NDC 68585000575, Pedigree: AD52993_4, EXP: 5/17/2014;  QUEtiapine FUMARATE, Tablet, 25 mg, NDC 65862048901, Pedigree: AD49582_22, EXP: 4/30/2014.", "address_2": "", "product_quantity": "2400 Tablets", "code_info": "AMANTADINE HCL, Tablet, 100 mg has the following codes:   Pedigree: AD54475_1, EXP: 5/20/2014;  Pedigree: AD54475_4, EXP: 5/20/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "AMANTADINE HCL, Tablet, 100 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00832011100.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-1013-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "5000 mL in Vials", "code_info": "a) Lot #: 160203-19, BUD: 08/01/16;  Lot #: 160222-60, BUD: 08/20/16.  b) Lot #: 160203-19, BUD: 08/01/16;  Lot #: 160222-60, BUD: 08/20/16.", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "MAGNESIUM CHL 200MG/ML (PF), In a) 5ML Vials and b) 10ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1211-216", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1196-2014", "product_description": "Pleo Not PORTABLE SIPS, 5X, 10 x 1mL Cartons, Oral Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2306-1.    Pleo Not PORTABLE SIPS, 5X, 50 x 1mL Cartons, Oral Homeopathic Medicine, OTC Only. Made in Germany, Distributed by: SANUM USA Corp.,1465 Slater Road, Fernadale, WA 98248;  Manufactured By: SANUM-Kehlbeck GmbH & Co. KG. NDC: 49807-2306-2.", "product_quantity": "730 10 x 1mL Cartons; 367 50 x 1 mL Cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "(10  x 1mL): Batch # 07099, EXP: August 2014; Batch # 15090; EXP: August 2015; Batch # 06120, EXP: November 2015; Batch #19023; EXP: January 2018.    (50 x 1ml) Portable Sips: Batch # 07099, EXP: August 2014; Batch # 15090; EXP: August 2015; Batch # 1110, EXP: October 2015; Batch #6120; EXP: November 2015;Batch # 19023; EXP January 2018."}, {"status": "Terminated", "city": "Vancouver", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85784", "recalling_firm": "Beaming White Llc", "address_1": "1205 Ne 95th St", "address_2": "Suite A", "postal_code": "98665-8960", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1357-2020", "product_description": "Koala Hand Sanitizer, Soothing Eucalyptus, 16 FL OZ.,  Antibacterial, (Ethyl Alcohol 68%), Manufactured by Beaming White LLC, 1205 NE 95th St., Vancouver, WA 98665", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug: active ingredient ethanol tested below label claim and there is presence of undeclared isopropyl alcohol.", "recall_initiation_date": "20200612", "center_classification_date": "20200626", "termination_date": "20240311", "report_date": "20200708", "code_info": "Lot #: 40820, Exp. Date 4/8/23"}, {"status": "Terminated", "city": "New Paltz", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89464", "recalling_firm": "Ultra Seal Corporation", "address_1": "521 Main St", "address_2": "N/A", "postal_code": "12561-1609", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0482-2022", "product_description": "Backache & Muscle Relief (acetaminophen 250 mg, magnesium salicylate-tetrahydrate 290mg, caffeine 50 mg) 2 tablets per packet, Mfd. for First Aid Direct, Mason, OH 45040, NDC 42961-111-832", "product_quantity": "5,107,565 packets", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20220124", "center_classification_date": "20220131", "termination_date": "20231016", "report_date": "20220209", "code_info": "Lot #: K9770, AK9770 Exp. Date 08/2022; AK9958, K9958 Exp. Date 12/2022; AK9717, Exp. Date 07/2022; AK9522, AK9641 , Exp. Date 03/2022; AK9817, Exp. Date 09/2022"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0117-2015", "product_description": "Phenol 10% injectable packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "50 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 06062014@44, Exp 9/4/2014; 07302014@14, Exp 10/28/2014", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "400", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Epinephrine (PF) 10mcg/mL in 0.9% Sodium Chloride, 5ml syringe, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060, NDC # 45183-0135-70", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1266-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-579-2015", "product_description": "Chloroquine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "10000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0233-2024", "product_description": "4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).", "product_quantity": "34000 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot GX1542, Exp. 01/01/2025"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-938-2015", "product_description": "Tranexamic Acid active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "20000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "77105", "recalling_firm": "The Harvard Drug Group", "address_1": "17177 N Laurel Park Dr Ste 233", "address_2": "", "postal_code": "48152-3951", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-0692-2017", "product_description": "Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI  NDC 0904-6509-04", "product_quantity": "36,990 tablets", "reason_for_recall": "Superpotent Drug; out of specification results for assay (manufacturer)", "recall_initiation_date": "20161227", "center_classification_date": "20170502", "termination_date": "20170727", "report_date": "20170510", "code_info": "LOT: T-00601 Exp: 04-2017", "more_code_info": ""}, {"status": "Terminated", "city": "Raleigh", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87531", "recalling_firm": "PNHC, LLC.", "address_1": "1105 Baslow Brook Ct", "address_2": "N/A", "postal_code": "27614-8863", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "FL, CA", "recall_number": "D-0365-2021", "product_description": "heal the world, moisturizing original hand sanitizer, Non-Sterile Solution, Alcohol Antiseptic, 70% Topical Solution, 9.6 FL OZ. (285 mL) bottle, Heal The World, LLC, Draper, UT 84020, UPC 6 19988 44038 0.", "product_quantity": "139,806 bottles", "reason_for_recall": "Labeling Not Elsewhere Classified: Hand sanitizer packaged in containers resembling drinking water bottles.", "recall_initiation_date": "20210310", "center_classification_date": "20210430", "termination_date": "20231016", "report_date": "20210512", "code_info": "Lots: SAA21, SAA24, SAA27, SAA22, SAA23, SAA29, SAA26, SAA28, SAA25, SAA32, SAA55, SAA56, SAA44, SAA60, expiration 5/2022"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88850", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0281-2022", "product_description": "Lidocaine Hydrochloride Topical Solution USP 4% (40 mg/mL), 50 mL glass bottles, Rx Only, Teligent Pharma Inc., Buena, NJ 08310,  NDC 52565-009-50", "product_quantity": "14,664 glass bottles", "reason_for_recall": "CGMP Deviations: Lots recalled because they were manufactured at the same facility using the same components as the products that had cracked seals in caps that were found to be superpotent.", "recall_initiation_date": "20211012", "center_classification_date": "20211213", "termination_date": "20240618", "report_date": "20211222", "code_info": "Lot #: 13058, Exp. date 02/2022 and 13768, Exp. date 05/2022", "more_code_info": ""}, {"status": "Terminated", "city": "New Delhi", "state": "", "country": "India", "classification": "Class II", "openfda": {"application_number": ["M017"], "brand_name": ["THERA CARE COLD HOT MEDICATED PATCH"], "generic_name": ["MENTHOL"], "manufacturer_name": ["Veridian Healthcare"], "product_ndc": ["71101-954"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["MENTHOL"], "rxcui": ["420222"], "spl_id": ["20d6f5cc-2c81-74a0-e063-6394a90abfed"], "spl_set_id": ["b1ce129d-06a1-7755-e053-2995a90abd7d"], "package_ndc": ["71101-954-05"], "is_original_packager": [true], "upc": ["0845717008181", "845717008181"], "unii": ["L7T10EIP3A"]}, "product_type": "Drugs", "event_id": "95595", "recalling_firm": "Unexo Life Sciences Private Limited", "address_1": "B16, Sector 4, Bawana Industrial Area", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0066-2025", "product_description": "THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL  60031 NDC 71101-954-05, UPC 8 45717 00818 1", "product_quantity": "279,936 patches", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20241024", "center_classification_date": "20241122", "termination_date": "20250916", "report_date": "20241204", "code_info": "UPC 8 45717 00818 1", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1032-2023", "product_description": "CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High Potassium, IV Bag, total volume = 500 mL, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0102-1", "product_quantity": "56 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-255940, Exp. 7/27/2023"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Methylcobalamin", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1124-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-672-2015", "product_description": "Famotidine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4716 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "LAKE FOREST", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078591"], "brand_name": ["HYDROMORPHONE HYDROCHLORIDE"], "generic_name": ["HYDROMORPHONE HYDROCHLORIDE"], "manufacturer_name": ["Teva Parenteral Medicines, Inc."], "product_ndc": ["0703-0018", "0703-0110", "0703-0113"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["HYDROMORPHONE HYDROCHLORIDE"], "rxcui": ["1724338", "1724340", "1724341"], "spl_id": ["c32108cc-7b73-4921-9f9e-54b3d60c1c6e"], "spl_set_id": ["f0b78db9-a38c-41bb-8233-5e93f7f18c5c"], "package_ndc": ["0703-0110-01", "0703-0110-03", "0703-0113-01", "0703-0113-03", "0703-0018-01"], "is_original_packager": [true], "upc": ["0307030110038"], "unii": ["L960UP2KRW"]}, "product_type": "Drugs", "event_id": "77836", "recalling_firm": "HOSPIRA INC, LAKE FOREST", "address_1": "275 NORTH FOREST DRIVE", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1080-2017", "product_description": "Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For:  Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01", "product_quantity": "14,300 vials", "reason_for_recall": "Presence of Particulate Matter: Silicone oil", "recall_initiation_date": "20170726", "center_classification_date": "20170809", "termination_date": "20180511", "report_date": "20170816", "code_info": "Lot #: 560053F, Exp. 01AUG2017"}, {"status": "Terminated", "city": "Franklin", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72271", "recalling_firm": "Diabetes Corporation of America dba DCA Pharmacy", "address_1": "233 Bedford Way", "address_2": "N/A", "postal_code": "37064-5527", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "KY, OH, TN", "recall_number": "D-0006-2016", "product_description": "Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527", "product_quantity": "129 vials", "reason_for_recall": "Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.", "recall_initiation_date": "20150923", "center_classification_date": "20151005", "termination_date": "20160112", "report_date": "20151014", "code_info": "Lot #: 101614, Exp 4/30/2015"}, {"status": "Ongoing", "city": "Hattiesburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90982", "recalling_firm": "Pharmacy Plus, Inc. dba Vital Care Compounder", "address_1": "115 S 40th Ave", "address_2": "N/A", "postal_code": "39402-6600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "AL, LA, MS, and TN", "recall_number": "D-0033-2023", "product_description": "GLYCERIN OPHTHALMIC DROPS 98.5% Solution, 10 mL droptainer, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS  39402", "product_quantity": "1 droptainer", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.", "recall_initiation_date": "20221007", "center_classification_date": "20221102", "report_date": "20221109", "code_info": "Lot: 65416, BUD: 10/13/2022"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70390", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W. Field Court, Suite 300", "address_2": "N/A", "postal_code": "60045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0385-2015", "product_description": "Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, Kannapolis, NC 28083, Marketed by VersaPharm Incorporated, Marietta, GA 30062, NDC 61748-202-60    .", "product_quantity": "23,449 jars", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed USP microbial tests.", "recall_initiation_date": "20150128", "center_classification_date": "20150210", "termination_date": "20171130", "report_date": "20150218", "code_info": "Lot # 1446800; Exp. 03/15  Lot # 1538100; Exp. 05/15  Lot # 1538101; Exp. 05/15  Lot # 1538200; Exp. 06/15  Lot # 1608200; Exp. 08/15"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0183-2019", "product_description": "Sermorelin/GHRP-2 9 mg/9 mg Powder, Pharm D Solutions, Houston, Texas --- NDC 69699-1715-10", "product_quantity": "250 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 03202018:46 Discard by: 9/16/2018; 05012018:56 Discard by: 10/28/2018"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-266-2014", "product_description": "Single Strength PGE1 20mcg 2ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "1 unit", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Tonawanda", "address_1": "100 Colvin Woods Pkwy", "reason_for_recall": "Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.", "address_2": "Ste 300", "product_quantity": "136 units", "code_info": "Lot#: 18098@1, Exp. 7/16/2018", "center_classification_date": "20180326", "distribution_pattern": "NY only", "state": "NY", "product_description": "Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL  Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01", "report_date": "20180328", "classification": "Class III", "openfda": {}, "recalling_firm": "Pine Pharmaceuticals, LLC", "recall_number": "D-0607-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79457", "termination_date": "20180423", "recall_initiation_date": "20180305", "postal_code": "14150-6974", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA201578"], "brand_name": ["SIROLIMUS"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-653", "55111-654"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIROLIMUS"], "rxcui": ["349208", "360110"], "spl_id": ["f9a9d4b5-1c61-a2e6-5511-84b3f4f9b24b"], "spl_set_id": ["2e6130e5-fa94-dcf8-605c-817bf396e93d"], "package_ndc": ["55111-653-30", "55111-653-01", "55111-654-30", "55111-654-01"], "is_original_packager": [true], "upc": ["0355111654018"], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "94535", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "US Nationwide.", "recall_number": "D-0504-2024", "product_description": "Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-653-01", "product_quantity": "1,176 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240501", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot H2200493; Exp 6/30/2025", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "100 ML", "code_info": "All lots distributed between November 2014 and May 2015;  04022015@36, 7/1/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Baclofen 2,500 mcg/ml Intrathecal Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1725-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89970", "recalling_firm": "Mylan Pharmaceuticals Inc", "address_1": "3711 Collins Ferry Rd", "address_2": "", "postal_code": "26505-2362", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA nationwide.", "recall_number": "D-0845-2022", "product_description": "Insulin Glargine (insulin glargine-yfgn) Injection, 100 units/mL (U-100), packaged in a 10 mL Multiple-Dose vial inside a carton, Rx only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Manufactured for: Mylan Specialty L.P., Morgantown, WV 26505, NDC 49502-393-80", "product_quantity": "89,665 vials", "reason_for_recall": "Labeling: Missing label on the vial", "recall_initiation_date": "20220412", "center_classification_date": "20220504", "termination_date": "20231018", "report_date": "20220504", "code_info": "Lot #: BF21002800, Exp 8/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA070583"], "brand_name": ["BUPIVACAINE HYDROCHLORIDE"], "generic_name": ["BUPIVACAINE HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-1159", "0409-1160", "0409-1162", "0409-1163", "0409-1165", "0409-9043", "0409-9046", "0409-9045", "0409-9042"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "substance_name": ["BUPIVACAINE HYDROCHLORIDE"], "rxcui": ["1012377", "1012384", "1012396", "1012404", "1672917", "1672919", "1724786", "1724787", "1724880", "1724884", "1725078", "1725082", "1867594", "1867596"], "spl_id": ["3c6a5b9f-4ea0-4ccd-a384-a90e4ad379e7"], "spl_set_id": ["02a845c3-4521-4926-e397-25ab536e7cf6"], "package_ndc": ["0409-1159-18", "0409-1159-01", "0409-1159-19", "0409-1159-02", "0409-1160-18", "0409-1160-01", "0409-1162-18", "0409-1162-01", "0409-1162-19", "0409-1162-02", "0409-1163-18", "0409-1163-01", "0409-1165-18", "0409-1165-01", "0409-1165-19", "0409-1165-02", "0409-9043-11", "0409-9043-01", "0409-9046-11", "0409-9046-01", "0409-9045-11", "0409-9045-01", "0409-9045-16", "0409-9045-17", "0409-9042-11", "0409-9042-01", "0409-9042-16", "0409-9042-17"], "is_original_packager": [true], "unii": ["7TQO7W3VT8", "30Q7KI53AK"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1095-2022", "product_description": "Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01", "product_quantity": "30 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "6 ml", "code_info": "All lots distributed between November 2014 and May 2015;    04132015@17, 10/10/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Tri-Mix (6.9/0.575/39.375) Injectable, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1787-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88552", "recalling_firm": "Charles Paint Research Inc", "address_1": "2401 E 85th St", "address_2": "N/A", "postal_code": "64132-2617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Michigan", "recall_number": "D-0792-2021", "product_description": "HAND SANITIZER (alcohol 80%), Alchol Antiseptic 80% topical solution, Hand Sanitizer non-sterile solution, Net weight (6 lbs 14.2 oz) 1 gallon; Net Quantity (3785 mL), Manufactured by Soapdaddy LLC, 2401 E. 85th Street, Kansas City, MO 64131", "product_quantity": "600 gallons", "reason_for_recall": "CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.", "recall_initiation_date": "20200902", "center_classification_date": "20210908", "termination_date": "20230929", "report_date": "20210915", "code_info": "Lot# 20-160, Exp 06/11/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0114-2020", "product_description": "Vitamin 9A/B Lyophilized, Vial For IM Use, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678339", "product_quantity": "6325 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-216-2014", "product_description": "Methylprednisolone 40mg PF 1ml, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "2084 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0223-2022", "product_description": "TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 7.5/ML INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 06012021:18 BUD: 10/23/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206125"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["65862-831", "65862-832", "65862-833"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["5aadf0b6-2c49-48d4-8d22-2fbf99dbf4e6"], "spl_set_id": ["42e99112-c402-4662-877f-9e3a84dff9f2"], "package_ndc": ["65862-831-30", "65862-831-90", "65862-831-01", "65862-831-05", "65862-832-30", "65862-832-90", "65862-832-01", "65862-832-05", "65862-833-30", "65862-833-90", "65862-833-01", "65862-833-05"], "is_original_packager": [true], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "95730", "recalling_firm": "Aurobindo Pharma USA Inc", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0078-2025", "product_description": "Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.", "product_quantity": "3336 bottles", "reason_for_recall": "cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit", "recall_initiation_date": "20241107", "center_classification_date": "20241129", "report_date": "20241211", "code_info": "Lot #: a) CFSB23001A, Exp 03/31/2025, CFSB23002A, Exp 07/31/2025; CFSB23003A, Exp 10/31/2025; CFSB23004A, Exp 10/31/2025; b) P2300196, 12/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200292"], "brand_name": ["DONEPEZIL HYDROCHLORIDE"], "generic_name": ["DONEPEZIL HYDROCHLORIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-275", "43547-276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DONEPEZIL HYDROCHLORIDE"], "rxcui": ["997223", "997229"], "spl_id": ["dcfd9a94-e1bc-4b53-ae6f-0200ee714917"], "spl_set_id": ["042a59ea-131a-4806-b0f4-2f791d4414e2"], "package_ndc": ["43547-275-03", "43547-275-09", "43547-275-11", "43547-276-03", "43547-276-09", "43547-276-11"], "is_original_packager": [true], "upc": ["0343547276034", "0343547275037"], "unii": ["3O2T2PJ89D"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0177-2024", "product_description": "Donepezil HCl Tablets, 5 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791.  NDC: 43547-275-09", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 17605", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0574-2019", "product_description": "Dr. King's Natural Medicine Homeopathic Muscle Maximizer, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955513322, NDC 57955-5133-2", "product_quantity": "291 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 010118AE Exp. 01/20; 050216L Exp. 05/2019; 092216E Exp. 09/2019"}, {"status": "Ongoing", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "72432", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0054-2016", "product_description": "Amidate (Etomidate Injection, USP), 40 mg/20 mL (2 mg/mL), LifeShield, 20 mL, Glass Abboject Syringe with male luer lock adapter, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-8060-29", "product_quantity": "24,100 Syringes", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of Specification(OOS) results for degradation product of etomidate was confirmed during stability testing.", "recall_initiation_date": "20150929", "center_classification_date": "20151021", "report_date": "20151028", "code_info": "Lot 34-531-DK, Exp 10/01/2015"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg may have potentially been mislabeled as one of the following drugs:  MELATONIN, Tablet, 1 mg, NDC 74312002832, Pedigree: W003717, EXP: 6/26/2014;  PYRIDOXINE HCL, Tablet, 50 mg, NDC 51645090901, Pedigree: AD46257_25, EXP: 5/15/2014;  CHOLECALCIFEROL, Capsule, 2000 units, NDC 00536379001, Pedigree: AD73521_7, EXP: 5/30/2014.", "address_2": "", "product_quantity": "180 CHEW Tablets", "code_info": "MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg has the following codes:   Pedigree: W003714, EXP: 6/26/2014;  Pedigree: AD46257_10, EXP: 5/15/2014;  Pedigree: AD73521_10, EXP: 5/30/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "MULTIVITAMIN/MULTIMINERAL, CHEW Tablet, 0 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536344308.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-930-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0552-2019", "product_description": "Dr. King's Natural Medicine Homeopathic 9-1-1 Burnout, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Dr. Asheville, NC 28806, UPC 357955597926, NDC 57955-5979-2", "product_quantity": "2898 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot Numbers: 032816F Exp. 03/19; 060816C Exp. 03/19; 082916A Exp. 08/19"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076264"], "brand_name": ["NALTREXONE HYDROCHLORIDE"], "generic_name": ["NALTREXONE HYDROCHLORIDE"], "manufacturer_name": ["SpecGx LLC"], "product_ndc": ["0406-1170"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NALTREXONE HYDROCHLORIDE"], "rxcui": ["1483744"], "spl_id": ["9ed13551-325e-4b82-a266-72fc89ed27dc"], "spl_set_id": ["06ff2d5a-e62b-4fa4-bbdb-01938535bc65"], "package_ndc": ["0406-1170-03", "0406-1170-01"], "is_original_packager": [true], "upc": ["0304061170017"], "unii": ["Z6375YW9SF"]}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1039-2022", "product_description": "Naltrexone Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, MFG: Mallinckrodt Inc., NDC 0406-1170-03", "product_quantity": "4 bottles/30 tablets per bottle", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86394", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "N/A", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Repackaged tablets sold to three physicians located in CA and GA.", "recall_number": "D-1624-2020", "product_description": "Nature-Throid, 1.5 Grain, (97.5 mg), (Thyroid U.S.P. 1.5 gr. (97.5mg)/Liothyronine (T3) 13.5mcg/Levothyroxine (T4) 57mcg, 90-count bottles, Rx Only, Mfg: RLC Labs; Cave Creek, AZ, Preferred Pharmaceuticals, Inc. NDC 68788-7605-09", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20200902", "center_classification_date": "20200924", "termination_date": "20240425", "report_date": "20200930", "code_info": "a) Lot #: A0220R, Exp. Date: 2/28/2021"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85725", "recalling_firm": "Pfizer Inc.", "address_1": "235 E 42nd St", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1342-2020", "product_description": "Duavee (conjugated estrogens/bazedoxifene) tablets 0.45/20 mg, packaged in 2 blister cards containing 15 tablets each (30 tablets), Rx Only, Distributed by Wyeth Pharmaceuticals LLC A subsidiary of Pfizer In Philadelphia, PA 19101 Made in Ireland, NDC 00008-1123-12", "product_quantity": "544400 packages", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20200527", "center_classification_date": "20200624", "termination_date": "20230630", "report_date": "20200701", "code_info": "Lot #: AF7814, 2021 AUG 31; AH6565, 2021 SEP 30, AP5189, 2020 SEP30; CG8921, 2022 FEB 28; CL6603, DH5847, 2022 MAR 31; T17703, T99214 2020 JUN 30, W46878, X07330, 2020 SEP 30; X99074, 2021 JUN 30"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0240-2023", "product_description": "TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221104@17", "more_code_info": ""}, {"status": "Terminated", "city": "Pharr", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86377", "recalling_firm": "The Protein Shoppe", "address_1": "101 E Interstate 2", "address_2": "N/A", "postal_code": "78577-6561", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1595-2020", "product_description": "Red-E Tablet, Proprietary Blend 3000 mg**, packaged in 1-count plastic bag stapled with cardboard labeling.", "product_quantity": "21,511 tablets", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.", "recall_initiation_date": "20200901", "center_classification_date": "20200924", "termination_date": "20220208", "report_date": "20200930", "code_info": "All lots."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-608-2015", "product_description": "D-Cycloserine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "50 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: VALSARTAN, Tablet, 80 mg may have potentially been mislabeled as one of the following drugs:  TEMAZEPAM, Capsule, 7.5 mg, NDC 00378311001, Pedigree: AD49418_1, EXP: 5/17/2014;  VALSARTAN, Tablet, 320 mg, NDC 00078036034, Pedigree: AD65475_7, EXP: 5/28/2014;  ISOSORBIDE MONONITRATE, Tablet, 20 mg, NDC 62175010701, Pedigree: AD67989_10, EXP: 5/28/2014;  CHOLECALCIFEROL, Tablet", "address_2": "", "product_quantity": "1440 Tablets", "code_info": "VALSARTAN, Tablet, 80 mg has the following codes:   Pedigree: AD52372_4, EXP: 5/17/2014;  Pedigree: AD65475_10, EXP: 5/28/2014;  Pedigree: AD68025_1, EXP: 5/28/2014;  Pedigree: AD70585_1, EXP: 5/29/2014;  Pedigree: W002768, EXP: 6/10/2014;  Pedigree: W003535, EXP: 6/21/2014;  Pedigree: AD62995_4, EXP: 5/28/2014;  Pedigree: AD73597_1, EXP: 5/31/2014;  Pedigree: W002616, EXP: 6/4/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "VALSARTAN, Tablet, 80 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035834.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-815-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0709-2021", "product_description": "HYDROMORPHONE HCL-BUPIVACAINE HCL-CLONIDINE HCL PF INJECTABLE 21 mL syringes in two strengths:  a) 20MG-20MG-60MCG/ML INJECTABLE, b) 5MG-5MG-100MCG/ML, Rx only,   Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "42 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: a) 09302020@30, BUD 10/23/2020, b) 10022020@14, BUD 10/30/2020"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212144"], "brand_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "generic_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-861", "68462-862", "68462-863", "68462-864", "68462-865"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CHLORPROMAZINE HYDROCHLORIDE"], "rxcui": ["991039", "991044", "991188", "991194", "991336"], "spl_id": ["440a4208-83cc-4ffa-952c-d9c0745c342a"], "spl_set_id": ["a6065ac5-a111-449b-b51b-8bc2907d1ddb"], "package_ndc": ["68462-861-01", "68462-861-10", "68462-862-01", "68462-862-10", "68462-863-01", "68462-863-10", "68462-864-01", "68462-864-10", "68462-865-01", "68462-865-10"], "is_original_packager": [true], "upc": ["0368462862018", "0368462864012", "0368462863015", "0368462861011"], "unii": ["9WP59609J6"]}, "product_type": "Drugs", "event_id": "95936", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0159-2025", "product_description": "chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01", "product_quantity": "3,888", "reason_for_recall": "CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.", "recall_initiation_date": "20241211", "center_classification_date": "20241223", "report_date": "20250101", "code_info": "Lot#: 17230132, Exp 12/2024; 17230449, Exp 01/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-530-2015", "product_description": "Avanafil active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "1000 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling:Label Mixup; medroxyPROGESTERone ACETATE, Tablet, 10 mg may be potentially mislabeled as    hydrALAZINE HCl, Tablet, 100 mg, NDC 23155000401, Pedigree: AD46312_13, EXP: 5/16/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "medroxyPROGESTERone ACETATE, Tablet, 10 mg has the following code    Pedigree: AD46312_19, EXP: 5/16/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "medroxyPROGESTERone ACETATE Tablet, 10 mg, Rx only, Distributed by: AidaPak Service, LLC,  NDC 59762374202", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-647-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Round Lake", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63189", "recalling_firm": "Baxter Healthcare Corp.", "address_1": "Route 120 And Wilson Rd", "address_2": "N/A", "postal_code": "60073-9799", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-1687-2012", "product_description": "10% Dextrose Injection USP, packaged in a 500 mL AVIVA Container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; product code 6E0163, NDC 0338-6347-03", "product_quantity": "2,976 containers", "reason_for_recall": "Chemical Contamination: The IV solutions were packaged in AVIVA containers which may contain trace levels of cumene hydroperoxide (CHP).", "recall_initiation_date": "20120921", "center_classification_date": "20120925", "termination_date": "20150504", "report_date": "20121003", "code_info": "Lot #: C832840, Exp 02/13", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1051-2023", "product_description": "fentaNYL, 5000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-5", "product_quantity": "94 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-273074, Exp. 8/28/2023; 17-273772, Exp. 9/7/2023."}, {"country": "United States", "city": "Edmond", "address_1": "14844 Bristol Park Blvd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "", "code_info": "Lots: C253 BUD: 12/12/2018; D016 BUD: 1/18/2019", "center_classification_date": "20181107", "distribution_pattern": "Nationwide.", "state": "OK", "product_description": "Estradiol 15mg pellet, 1 count (NDC 69761-015-01), 6 count (NDC 69761-015-06), 12 count (NDC 69761-015-12), and 30 count (NDC 69761-015-30) vials, Rx Only, Qualgen, LLC, Edmond, OK 73013", "report_date": "20181114", "classification": "Class II", "openfda": {}, "recalling_firm": "Qualgen, LLC", "recall_number": "D-0227-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81346", "termination_date": "20200604", "more_code_info": "", "recall_initiation_date": "20181017", "postal_code": "73013-1891", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Hallandale Beach", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80699", "recalling_firm": "Pharmcore Inc.", "address_1": "1109 E Hallandale Beach Blvd", "address_2": "N/A", "postal_code": "33009-4431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1153-2018", "product_description": "Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009", "product_quantity": "6 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20180802", "center_classification_date": "20180828", "termination_date": "20220118", "report_date": "20180905", "code_info": "Lot: IPA3-17 Exp. 07/2018"}, {"status": "Terminated", "city": "Meridian", "state": "ID", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74725", "recalling_firm": "Medicap Pharmacy", "address_1": "2790 W Cherry Ln Ste 100", "address_2": "N/A", "postal_code": "83642-1102", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "ID", "recall_number": "D-1447-2016", "product_description": "Acetylcyst 10% OPHT SOL, 10%, 15 mL bottle, Rx only, Medicap Pharmacy, 2790 W Cherry Lane, Meridian, ID  83642, NDC 99999-9996-94.", "product_quantity": "1 bottle", "reason_for_recall": "Lack of Assurance of Sterility: Sterile products were not produced in a controlled, sterile environment.", "recall_initiation_date": "20160707", "center_classification_date": "20160722", "termination_date": "20160808", "report_date": "20160803", "code_info": "Lot #: 05092016@19, Beyond Use Date: 06/08/16; Discard After 09/01/2017."}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076557"], "brand_name": ["LORATADINE AND PSEUDOEPHEDRINE SULFATE"], "generic_name": ["LORATADINE AND PSEUDOEPHEDRINE SULFATE"], "manufacturer_name": ["STRATEGIC SOURCING SERVICES"], "product_ndc": ["49348-543"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["LORATADINE", "PSEUDOEPHEDRINE SULFATE"], "rxcui": ["1117562"], "spl_id": ["6459b34c-2237-4931-af7a-507effd2daf0"], "spl_set_id": ["114b5e7c-973a-4a34-8538-a214de090b39"], "package_ndc": ["49348-543-01", "49348-543-57", "0504280496", "0933511162", "30142-0724-69", "46122-0167-52", "37808-0724-69", "0118223315"], "is_original_packager": [true], "unii": ["7AJO3BO7QN", "Y9DL7QPE6B"], "upc": ["050428049631", "093351116285", "011822331555"]}, "product_type": "Drugs", "event_id": "67631", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA OH, PA, RI,& TX", "recall_number": "D-1256-2014", "product_description": "Non-Drowsy 24 Hour Formula Allergy Relief and Nasal Decongestant, Pseudoephedrine Sulfate, USP 240 mg , Loratadine, USP, 10 mg, 5, 10, 15 count blister packs, OTC Only. Labeled A) CVS Allergy Relief - D, Pseudoephedrine, USP 240 mg/Nasal Decongestant Loratadine, USP 10 mg/Antihistamine Extended Release Tablets, 5-count box  Distributed by CVS Pharmacy Inc., One CVS Drive, Woonsocket, RI 02805 UPC 050428049631    B) Discount Drug Mart Non-Drowsy 24 Hour Formula  Allergy Relief and Nasal Decongestant, Loratadine, USP 10 mg/Antihistamine Pseudephrine Sulfate, USP 240 mg/Nasal Decongestant  Extended Release Tablets, 15-count box  Distributed by Drug Mart-Food Fair Medina, Ohio 44256 UPC 093351116285    C) Kroger Non-Drowsy Allergy and Congestion Loratadine and Pseudoephedrine Extended Release Tablets  Pseudoephedrine Sulfate, USP 240 mg Nasal Decongestant  Loratadine, USP 10 mg, Antihistamine 10- count box, Distributed by The Kroger Co., Cincinnati, Ohio 45202  NDC 30142-0724-69.    D) Sunmark Allergy & Congestion Lorata*dine D Pseudoephedrine Sulfate, USP 240 mg/Nasal Decongestant Loratadine, USP 10 mg/Antihistamine Extended Release Tablets, Indoor & Outdoor Allergies, Non-Drowsy 10- count box, Distributed by Mckesson One Post Street, San Francisco, CA 94104 NDC 49348-543-01    E) Good Neighbor Pharmacy  Non-Drowsy Allergy and Congestion Relief  pseudoephedrine sulfate, USP 240 mg/nasal decongestant loratadine, USP 10 mg/antihistamine Indoor & Outdoor Allergies Extended-Release Tablets, 10- count box, Distributed by Amerisource Bergen 1300 Morris Drive, Chesterbrook, PA 19087 NDC46122-0167-52    F) H-E-B Allergy Relief - D Non-Drowsy- 24 Hour Formula Loratadine, USP 10mg/Antihistamine Pseudoephedrine Sulfate, USP 240 mg/Nasal Decogestant Indoor & Outdoor Allegies, Allergy & Congestion Extended-Release Tablets 10-count box, Distributed by H-E-B San Antonio, TX 78204    NDC 37808-0724-69    G) Rite Aid Pharmacy allergy relief & nasal decongestant loratadine USP, 10 mg, pseudoephedribe sulfate USP, 240 mg, antihistamine & nasal degestant,  extended release tablets, 10- count box,  Distributed by: Rite Aid 30 Hunter Lane Camp Hill, PA 17011   UPC 0118223315555", "product_quantity": "29,790 blister packs", "reason_for_recall": "Defective Container: An unacceptable level of blister defects have been identified in Loratadine and Pseudoephedrine Sulfate Extended Release Tablets, 10 mg/240 mg.", "recall_initiation_date": "20140207", "center_classification_date": "20140423", "termination_date": "20150501", "report_date": "20140430", "code_info": "Lot # 2554936, 2554938; Exp 09/15", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "61918", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide Puerto Rico, U.S. Virgin Island, Libya, Saudi Arabia", "recall_number": "D-619-2013", "product_description": "0.9% Sodium Chloride Injection, USP, a) 50 mL (NDC 0409-7984-13), b) 50 mL (NDC 0409-7984-36), c) 100 mL (0409-7984-37), Rx Only, Hospira, Inc., Lake Forest, IL 60045", "product_quantity": "2,933,936 units", "reason_for_recall": "Lack of Assurance of Sterility: Hospira, Inc is voluntarily recalling the products due to possible leaking bags.", "recall_initiation_date": "20120504", "center_classification_date": "20130621", "termination_date": "20150717", "report_date": "20130703", "code_info": "Lot #: a) 11-085-JT, Exp 11/13; b) 06-111-JT, Exp 12/12, c) 93-030-JT, 14-044-JT, Exp 9/12", "more_code_info": ""}, {"status": "Terminated", "city": "Torrance", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "81741", "recalling_firm": "Asclemed USA Inc. dba Enovachem", "address_1": "379 Van Ness Ave Ste 1403", "address_2": "", "postal_code": "90501-7211", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Natonwide", "recall_number": "D-0353-2019", "product_description": "Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-0750-01", "product_quantity": "", "reason_for_recall": "Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recalled by the manufacturer due to the product insert incorrectly stating stoppers do not contain latex. The stoppers contain natural rubber latex", "recall_initiation_date": "20181211", "center_classification_date": "20190109", "termination_date": "20230201", "report_date": "20181226", "code_info": "Lot #: 050518X5, 051618X1, Exp 1/31/19; 052318X4, Exp 5/1/19; 052318X5, 062818X1, 072518X3, 072718X1, 080318X2, 091818X2, Exp 5/31/19; 082318X4, 083118X1, 090518X4, 091818X4, Exp 6/30/19; 091818X3, Exp 7/31/19; 091818X5, 092418X1, 092818X4, 101018X3, 101018X5, Exp 8/31/19; 102418X5, Exp 9/30/19", "more_code_info": ""}, {"country": "United States", "city": "Ocala", "address_1": "1210 SW 33rd Avenue", "reason_for_recall": "Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.", "address_2": "", "product_quantity": "1 unit", "code_info": "Rx #:   0410015", "center_classification_date": "20120810", "distribution_pattern": "Nationwide, Bahamas, Columbia, Dominican Republic, Grand Cayman, Guatemala, Poland, Santo Domingo, Venezuela, and West Indies", "state": "FL", "product_description": "ENGERIX-B, SDV** 20MCG/ML INJECTABLE 1 ML (1 PRODUCT)", "report_date": "20120822", "classification": "Class II", "openfda": {}, "recalling_firm": "Franck's Lab Inc., d.b.a. Franck's Compounding Lab", "recall_number": "D-1513-2012", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "62416", "termination_date": "20140813", "more_code_info": "", "recall_initiation_date": "20120525", "postal_code": "34474-5138", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "85801", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the  USA", "recall_number": "D-1340-2020", "product_description": "Prednisolone Sodium Phosphate Oral Solution, 5 mg/5 mL, 120 mL Bottle, Rx only, HI-TECH PHARMACAL CO., INC., Amityville, NY 11701.  NDC:  50383-040-04", "product_quantity": "17,424 bottles", "reason_for_recall": "Discoloration: Out of Specification (OOS) result for APHA Color Test.", "recall_initiation_date": "20200605", "center_classification_date": "20200624", "termination_date": "20220728", "report_date": "20200617", "code_info": "Lot# 365566, 365568"}, {"status": "Ongoing", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90566", "recalling_firm": "Family Dollar Stores, Llc.", "address_1": "500 Volvo Pkwy", "address_2": "", "postal_code": "23320-1604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-1395-2022", "product_description": "QP MOTION SICKNESS TABLET 8 CT distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.", "product_quantity": "Unknown", "reason_for_recall": "CGMP Deviations: product held outside appropriate storage temperature conditions.", "recall_initiation_date": "20220623", "center_classification_date": "20220822", "report_date": "20220831", "code_info": "SKU: 901583", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0786-2023", "product_description": "Artificial Tears Ointment, Sterile, For Ophthalmic Use Only, 3.5 gram tubes, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Horsham", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "66594", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "425 Privet Rd", "address_2": "", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-392-2014", "product_description": "Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus\u00bf\u00bf labels.  NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial)", "product_quantity": "13520 vials", "reason_for_recall": "Presence of Precipitate; precipitation of drug product", "recall_initiation_date": "20131011", "center_classification_date": "20131230", "termination_date": "20140827", "report_date": "20140108", "code_info": "Lot number                      EXP               31314801B,  2/2014;  31314990B,  2/2014;  31314991B,  2/2014;  31315014B,  2/2014;  31315155B,  6/2014;  31315279B,  6/2014;   31315837B,  10/2014;  31315921B,  10/2014;  31316029D,                    12/2014; and   31316029C,                    12/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Spokane", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83253", "recalling_firm": "First Pharma Associates LLC dba Riverpoint Pharmacy", "address_1": "1802 N Monroe St", "address_2": "", "postal_code": "99205-4528", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "ID, WA only", "recall_number": "D-1478-2019", "product_description": "Methylcobalamin 10 mg/mL Injection, 5.4 mL vial, Rx only,  First Pharma Associates dba Riverpoint Pharmacy, Spokane, WA 99205, (509) 343-6252.", "product_quantity": "5.4 mL", "reason_for_recall": "Lack of Assurance of Sterility.", "recall_initiation_date": "20190626", "center_classification_date": "20190711", "termination_date": "20230606", "report_date": "20190717", "code_info": "Lot #: 06202019@29, Exp. 08/19/2019", "more_code_info": ""}, {"status": "Terminated", "city": "Vicksburg", "state": "MS", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79748", "recalling_firm": "Kroger Specialty Pharmacy, Inc.", "address_1": "100 Pear Orchard Dr Ste A", "address_2": "N/A", "postal_code": "39180-7153", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MS, LA, AR, IL, FL", "recall_number": "D-0741-2018", "product_description": "Taltz 80 mg/mL Pen 1-pk NDC 00002-1445-11 28 days supply", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20180403", "center_classification_date": "20180510", "termination_date": "20200507", "report_date": "20180516", "code_info": "All lots remaining within expiry dispensed 12/01/2017 through 02/12/2018"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0921-2019", "product_description": "NET Remedies #5 Homeopathic Preparation, Oral Liquid, 57 mL, Manufacturer: King Bio Inc. U.S.A., Supplier: NET (Australia) Pty LTD 428 Hume Street, Toowoomba QLD 4350, Australia", "product_quantity": "2200 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: AUS-011117E Exp. 01/20; AUS-011916E Exp. 01/19; AUS-030816E Exp. 03/19; AUS-050516E Exp. 05/19; AUS-101116A Exp. 10/19"}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2000 mL in Vials", "code_info": "Lot #: 151218-28, BUD: 06/15/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "METHYL B12 1000MCG/ML IN NACL 0.9% (PF), 2ML Vials, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1217-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "9 containers", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Dep-Estradiol 10 mg/mL Injection, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0402-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}]